NASDAQ: NTWK

NETSOL TECHNOLOGIES INC

CIK 0001039280 · SIC 7372 · Prepackaged Software

Small Revenue $78M Assets $78M as of Nov 1, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (YELP 10-Q) is open in full — no account needed.

8-K Filed Nov 13, 2026 · Period ending Nov 12, 2026

Summary not yet generated.

10-Q Filed Nov 12, 2026 · Period ending Sep 30, 2026

Summary not yet generated.

Partner

Trade NTWK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Nov 4, 2026 · Period ending Nov 4, 2026

Summary not yet generated.

8-K Filed Sep 29, 2026 · Period ending Sep 28, 2026

Summary not yet generated.

10-K Filed Sep 28, 2026 · Period ending Jun 30, 2026

Summary not yet generated.

8-K Filed Jun 22, 2026 · Period ending Jun 18, 2026

Summary not yet generated.

10-Q Filed May 14, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

8-K Filed May 14, 2026 · Period ending May 14, 2026

Summary not yet generated.

10-Q Filed Feb 12, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-K Filed Sep 29, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

424B5 Filed Mar 2, 2012

Summary not yet generated.

424B5 Filed Feb 15, 2012

Summary not yet generated.

424B5 Filed Feb 14, 2012

Summary not yet generated.

10-Q/A Filed Dec 23, 2011 · Period ending Sep 30, 2011

Summary not yet generated.

10-K/A Filed Jul 28, 2011 · Period ending Jun 30, 2010

Summary not yet generated.

Latest financial statements

From 10-Q filed Nov 12, 2026 (period ending Sep 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Condensed Consolidated Statements of Operations (Unaudited)

Description Three months ended September 30, 2026 Three months ended September 30, 2025
Net Revenues:
License fees 549,263 72,225
Subscription and support 9,505,208 8,960,555
Services 6,357,989 5,979,143
Total net revenues 16,412,460 15,011,923
Cost of revenues 8,131,365 9,099,933
Gross profit 8,281,095 5,911,990
Operating expenses:
Selling, general and administrative 7,700,709 7,536,353
Research and development cost 171,626 214,343
Total operating expenses 7,872,335 7,750,696
Income (loss) from operations 408,760 (1,838,706)
Other income and (expenses)
Interest expense (111,360) (174,611)
Interest income 301,068 280,974
Gain (loss) on foreign currency exchange transactions (6,811) (286,917)
Other income 47,677 17,670
Total other income (expenses) 230,574 (162,884)
Net income (loss) before income taxes 639,334 (2,001,590)
Income tax provision (105,126) (215,775)
Net income (loss) 534,208 (2,217,365)
Non-controlling interest (371,239) (139,923)
Net income (loss) attributable to NetSol 162,969 (2,357,288)
Net income (loss) per share:
Net income (loss) per common share
Basic 0.01 (0.21)
Diluted 0.01 (0.21)
Weighted average number of shares outstanding
Basic 11,906,981 11,429,695
Diluted 11,926,869 11,429,695

Condensed Consolidated Balance Sheets (Unaudited)

Description As of September 30, 2026 As of June 30, 2026
ASSETS
Current assets:
Cash and cash equivalents 19,697,789 27,123,955
Accounts receivable, net of allowance of $161,853 and $48,606 9,144,194 10,286,342
Contract assets, net of allowance of $0 and $10 18,977,455 16,240,564
Other current assets 4,160,460 3,210,315
Total current assets 51,979,898 56,861,176
Contract assets, net long term 2,483,199 2,467,018
Property and equipment, net 5,550,633 5,683,502
Right of use assets operating leases 795,642 831,196
Other assets 7,242 7,241
Other intangible assets, net 3,619,868 2,686,392
Goodwill 9,302,524 9,302,524
Total assets 73,739,006 77,839,049
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses 7,276,077 8,708,029
Current portion of loans and obligations under finance leases 8,139,155 8,187,170
Current portion of operating lease obligations 499,603 447,332
Contract liabilities 6,941,958 10,287,225
Total current liabilities 22,856,793 27,629,756
Loans and obligations under finance leases; less current maturities 174,082 212,982
Operating lease obligations; less current maturities 260,146 428,491
Total liabilities 23,291,021 28,271,229
Stockholders’ equity:
Preferred stock, $.01 par value; 500,000 shares authorized; - -
Common stock, $.01 par value; 18,000,000 shares authorized; 12,910,343 shares issued and 11,971,312 outstanding as of September 30, 2026 ,12,825,028 shares issued and 11,885,997 outstanding as of June 30, 2026 129,106 128,253
Additional paid-in-capital 130,276,620 130,188,049
Treasury stock (at cost, 939,031 shares as of September 30, 2026 and June 30, 2026) (3,920,856) (3,920,856)
Accumulated deficit (38,175,758) (38,338,727)
Other comprehensive loss (46,295,697) (46,462,794)
Total NetSol stockholders’ equity 42,013,415 41,593,925
Non-controlling interest 8,434,570 7,973,895
Total stockholders’ equity 50,447,985 49,567,820
Total liabilities and stockholders’ equity 73,739,006 77,839,049

Condensed Consolidated Statements of Cash Flows (Unaudited)

Description Three months ended September 30, 2026 Three months ended September 30, 2025
Cash flows from operating activities:
Net income (loss) 534,208 (2,217,365)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization 332,284 324,606
Provision for bad debts 112,794 (1,583)
Gain on sale of assets (46,594) (16,613)
Stock based compensation 102,900 145,400
Changes in operating assets and liabilities:
Accounts receivable 1,105,032 1,218,992
Contract assets (2,639,619) 4,282,495
Other current assets (172,448) (323,491)
Accounts payable and accrued expenses (1,476,931) 1,176,241
Contract liabilities (3,407,627) 714,879
Net cash provided by (used in) operating activities (5,556,001) 5,303,561
Cash flows from investing activities:
Purchases of property and equipment (976,009) (485,281)
Sales of property and equipment 46,594 16,687
Investment in associates - 25,396
Increase in intangible assets (1,001,481) -
Net cash used in investing activities (1,930,896) (443,198)
Cash flows from financing activities:
Proceeds from exercise of subsidiary options 20,292 64,147
Proceeds from bank loans - 242,421
Payments on finance lease obligations and loans net (119,298) (115,350)
Net cash provided by (used in) financing activities (99,006) 191,218
Effect of exchange rate changes 159,737 281,093
Net increase (decrease) in cash and cash equivalents (7,426,166) 5,332,674
Cash and cash equivalents at beginning of the period 27,123,955 17,357,944
Cash and cash equivalents at end of period 19,697,789 22,690,618

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗